av/aptevo-therapeutics--big.svg

NASDAQ:APVO

Aptevo Therapeutics

  • Stock

USD

Last Close

1.47

06/11 22:27

Market Cap

2.78M

Beta: 5.32

Volume Today

406.93K

Avg: 60.96K

PE Ratio

0.07

PFCF: −0.27

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
revenue
45.63M
-
33.60M
26.36%
36.43M
8.43%
14.66M
59.77%
23.07M
57.37%
32.42M
40.56%
4.31M
86.71%
12.29M
185.26%
3.11M
74.67%
cost of revenue
16.25M
-
16.93M
4.18%
24.18M
42.81%
5.01M
79.28%
11.21M
123.83%
19.93M
77.70%
567K
-
352K
37.92%
gross profit
29.38M
-
16.67M
43.26%
12.25M
26.49%
9.65M
21.25%
11.85M
22.85%
12.50M
5.43%
4.31M
65.52%
12.29M
185.26%
3.11M
74.67%
-567K
118.21%
selling and marketing expenses
general and administrative expenses
13.95M
-
14.70M
5.35%
13.87M
5.61%
11.77M
15.15%
10.22M
13.14%
selling general and administrative expenses
34.28M
-
43.04M
25.56%
38.67M
10.17%
34.58M
10.58%
28.13M
18.63%
16.20M
42.42%
13.95M
13.88%
14.70M
5.35%
13.87M
5.61%
11.77M
15.15%
10.22M
13.14%
research and development expenses
46.59M
-
34.73M
25.46%
29.52M
15.00%
29.02M
1.68%
35.38M
21.93%
24.76M
30.02%
17.85M
27.91%
18.99M
6.40%
17.88M
5.85%
16.54M
7.50%
14.03M
15.20%
other expenses
34.28M
-
43.04M
25.56%
38.67M
10.17%
34.58M
10.58%
-2.02M
105.85%
-2.10M
3.85%
-1.32M
36.96%
-8.01M
504.38%
-1.53M
80.93%
cost and expenses
97.12M
-
94.70M
2.49%
92.37M
2.47%
68.61M
25.72%
74.73M
8.93%
40.96M
45.19%
31.80M
22.36%
33.69M
5.94%
31.75M
5.75%
28.88M
9.06%
operating expenses
80.87M
-
77.77M
3.83%
68.18M
12.32%
63.60M
6.73%
63.52M
0.12%
40.96M
35.51%
31.80M
22.36%
33.69M
5.94%
31.75M
5.75%
28.31M
10.85%
24.60M
13.10%
interest expense
-35.66M
-
ebitda
-49.25M
-
-57.96M
17.68%
19.25M
133.22%
-48.88M
353.87%
-49.27M
0.81%
-38.73M
21.41%
-25.39M
34.44%
-21.40M
15.71%
-64.92M
203.37%
-28.31M
56.39%
-23.78M
16.01%
operating income
-51.49M
-
-61.10M
18.66%
-126.94M
107.77%
-53.95M
57.50%
-51.66M
4.23%
-40.96M
20.72%
-27.49M
32.88%
-21.40M
22.16%
-28.64M
33.84%
-28.88M
0.83%
-24.60M
14.81%
depreciation and amortization
2.02M
-
2.91M
43.84%
3.36M
15.65%
3.13M
6.99%
2.39M
23.57%
2.23M
6.49%
2.10M
5.86%
1.14M
45.63%
-36.28M
3,271.42%
567K
101.56%
352K
37.92%
total other income expenses net
-222K
-
-237K
6.76%
-71.82M
30,205.06%
-1.94M
97.29%
-2.02M
4.12%
-2.10M
3.85%
-3.43M
63.13%
-8.01M
133.54%
35.66M
545.24%
10.23M
71.31%
472K
95.39%
income before tax
-51.71M
-
-61.34M
18.61%
-127.75M
108.28%
-55.89M
56.25%
-53.69M
3.94%
-43.06M
19.79%
-30.92M
28.19%
-29.41M
4.90%
7.01M
123.85%
-18.65M
365.90%
-24.13M
29.38%
income tax expense
-599K
-
-2.02M
237.23%
-15.34M
659.41%
-23.30M
51.90%
-2.02M
91.31%
-2.62M
29.25%
-12.47M
376.87%
-2.10M
83.21%
-35.66M
1,601.91%
-1.24M
96.53%
net income
-51.12M
-
-59.32M
16.05%
-112.42M
89.52%
6.97M
106.20%
-53.69M
869.96%
-40.45M
24.66%
-18.45M
54.39%
-27.31M
48.05%
42.67M
256.22%
-17.41M
140.80%
-24.13M
38.59%
weighted average shs out
1.41M
-
1.41M
0%
1.45M
2.37%
1.52M
5.42%
1.61M
5.46%
2.92M
81.50%
3.39M
16.25%
4.69M
38.25%
5.10M
8.80%
278.06K
94.55%
276.14K
0.69%
weighted average shs out dil
1.41M
-
1.41M
0%
1.45M
2.37%
1.52M
5.42%
1.61M
5.46%
2.92M
81.50%
3.39M
16.25%
4.69M
38.25%
5.10M
8.85%
278.06K
94.55%
276.14K
0.69%
eps
-36.19
-
-42
16.05%
-77.76
85.14%
4.62
105.94%
-33.41
823.16%
-13.87
58.49%
-5.44
60.78%
-5.83
7.17%
8.37
243.57%
-62.62
848.15%
-84.67
35.21%
epsdiluted
-36.19
-
-42
16.05%
-77.76
85.14%
4.62
105.94%
-33.41
823.16%
-13.87
58.49%
-5.44
60.78%
-5.83
7.17%
8.36
243.40%
-62.62
849.04%
-84.67
35.21%

All numbers in USD (except ratios and percentages)